Видео ютуба по тегу Aimmune

Watch CNBC's interview with Aimmune Therapeutics CEO on the company's peanut therapy
Watch CNBC's interview with Aimmune Therapeutics CEO on the company's peanut therapy
Aimmune Therapeutics confirms $2B Nestle acquisition
Aimmune Therapeutics confirms $2B Nestle acquisition
FDA panel recommends Aimmune's peanut allergy treatment
FDA panel recommends Aimmune's peanut allergy treatment
Aimmune™ Therapeutics - Allergy Immunology
Aimmune™ Therapeutics - Allergy Immunology
Latitude Founder's 16 year old daughter, Tessa Grosso testifying at the FDA panel for Aimmune.
Latitude Founder's 16 year old daughter, Tessa Grosso testifying at the FDA panel for Aimmune.
Aimmune Therapeutics - An oral study by Aimmune
Aimmune Therapeutics - An oral study by Aimmune
Former Aimmune Therapeutics CEO: Taking Stock in Allergies | Mad Money
Former Aimmune Therapeutics CEO: Taking Stock in Allergies | Mad Money
Aimmune Therapeutics' CEO and Office Environment - Q1 2019
Aimmune Therapeutics' CEO and Office Environment - Q1 2019
Food allergies an immense opportunity, Nestle Health Science chief says
Food allergies an immense opportunity, Nestle Health Science chief says
Bay Area Firm May Be On Verge Of Peanut Allergy Cure
Bay Area Firm May Be On Verge Of Peanut Allergy Cure
003 - Aimmune shows positive Phase 3 data for Peanut Allergy!
003 - Aimmune shows positive Phase 3 data for Peanut Allergy!
Peanut protein powder shows potential for treating allergies
Peanut protein powder shows potential for treating allergies
Nestle buys peanut allergy treatment maker
Nestle buys peanut allergy treatment maker
Working at Aimmune Therapeutics - May 2018
Working at Aimmune Therapeutics - May 2018
FDA clears the first treatment for kids with peanut allergy
FDA clears the first treatment for kids with peanut allergy
News of Note: Peanut Allergy Breakthrough
News of Note: Peanut Allergy Breakthrough
Peace of Mind
Peace of Mind
Nestle secures peanut allergy treatment
Nestle secures peanut allergy treatment
Breakthrough Wednesday | The Next Generation of Food Allergy Diagnostics
Breakthrough Wednesday | The Next Generation of Food Allergy Diagnostics
Protecting children from severe peanut allergies
Protecting children from severe peanut allergies
Simon Murray, MD: A Competitive Food Allergy Therapy Market
Simon Murray, MD: A Competitive Food Allergy Therapy Market
Biotech Stock On The Radar: Aimmune (AIMT stock) Awaits Adcom Test
Biotech Stock On The Radar: Aimmune (AIMT stock) Awaits Adcom Test
Efficacy, safety, and quality of life with extended daily OIT in children with peanut allergy
Efficacy, safety, and quality of life with extended daily OIT in children with peanut allergy
Генеральный директор Nestle о приобретении компанией Aimmune Therapeutics
Генеральный директор Nestle о приобретении компанией Aimmune Therapeutics
Nestle Pays $2 Billion To Secure Aimmune's Allergy Treatment
Nestle Pays $2 Billion To Secure Aimmune's Allergy Treatment